18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
暂无分享,去创建一个
Darrin W. Byrd | Paul Kinahan | D. Mankoff | H. Linden | B. Kurland | R. Doot | M. Muzi | K. Krohn | J. Link | L. Peterson | J. Specht | A. Novakova-Jiresova | P. Romine | P. E. Romine | Alena Novakova-Jiresova